Ren Guibing | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Ren Guibing | Medicine and Dentistry | Best Researcher Award

Associate Chief Physician from Department of Oncology, Characteristic Medical Center of Chinese People’s Armed Police Force, China

Assoc. Prof. Dr. Ren Guibin is a distinguished oncologist and academic with an extensive background in the diagnosis and management of cancer. He currently serves as the Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. With over 30 peer-reviewed publications, Dr. Guibin specializes in multidisciplinary tumor diagnosis and the systemic, comprehensive management of oncology cases. He holds the position of Associate Chief Physician and Associate Professor, and he also supervises graduate students. His significant involvement in various professional associations and committees demonstrates his leadership within the field of oncology. Dr. Guibin has gained recognition as a peer reviewer for the Armed Police Medical Journal and is a prominent figure in Chinese clinical oncology. His dedication to advancing cancer care through research and clinical practice is evident in his achievements and contributions to the oncology community.

Professional Profile

Education

Dr. Ren Guibin earned his medical degree (M.D.) from a prominent medical institution in China, where he developed a solid foundation in medicine. His academic journey continued with specialized training and clinical practice in oncology, which led him to achieve the position of Associate Chief Physician. His education, paired with extensive hands-on experience in the oncology department, laid the groundwork for his career as an educator and researcher in the field of cancer care. Throughout his career, Dr. Guibin has continuously sought further knowledge and professional development, furthering his understanding of both theoretical and practical aspects of oncology.

Professional Experience

Assoc. Prof. Dr. Ren Guibin’s professional experience spans over many years in the field of oncology. He holds the position of Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. Dr. Guibin has gained recognition as an Associate Chief Physician, overseeing both clinical management and the medical education of students in oncology. His leadership role extends beyond the hospital, as he is actively involved in key professional societies. As a Master’s supervisor, Dr. Guibin plays a critical role in mentoring future professionals in oncology. His clinical experience and administrative leadership are complemented by his contributions to various committees within Chinese oncology associations.

Research Interests

Dr. Ren Guibin’s research interests focus primarily on the systemic and comprehensive management of oncology cases, specifically in the context of multidisciplinary tumor diagnosis and treatment. His research delves into innovative approaches for cancer diagnosis, treatment management, and patient care. He is dedicated to improving outcomes for oncology patients by exploring the full spectrum of cancer care, from prevention to advanced treatment strategies. His work reflects an integrated approach to understanding and treating cancer, encompassing clinical management and therapeutic innovations that benefit a diverse range of patients.

Research Skills

Assoc. Prof. Dr. Ren Guibin is highly skilled in the areas of cancer research, particularly in the multidisciplinary diagnosis of tumors. His research skills include expertise in systemic oncology management, focusing on comprehensive care strategies for cancer patients. Dr. Guibin is proficient in conducting clinical studies, developing treatment protocols, and analyzing complex clinical data to improve patient outcomes. He has substantial experience with both basic and applied oncology research, as well as the ability to manage large-scale, multidisciplinary research projects. Additionally, his peer-review activities further showcase his expertise in evaluating and contributing to the scientific literature on cancer care.

Awards and Honors

Throughout his distinguished career, Assoc. Prof. Dr. Ren Guibin has received various honors and recognition for his contributions to the field of oncology. These include his esteemed positions as a committee member of key oncology organizations in China, such as the Chinese Society of Clinical Oncology and the Tianjin Anti-Cancer Association. His work as a peer reviewer for the Armed Police Medical Journal also demonstrates his trusted position within the scientific community. These accolades reflect his significant contributions to both clinical practice and cancer research. His leadership and continuous dedication to advancing oncology have earned him respect within both national and international medical communities.

Conclusion

Assoc. Prof. Dr. Ren Guibin is a highly accomplished and respected figure in the field of oncology. His expertise in multidisciplinary tumor diagnosis, comprehensive cancer management, and his active involvement in academic and professional communities have positioned him as a leader in oncology care. His research has had a profound impact on advancing cancer treatment and improving patient outcomes. Dr. Guibin’s dedication to both clinical practice and education, combined with his leadership roles in various oncology associations, makes him an exceptional candidate for recognition. His continued contributions to the field promise to drive further progress in the fight against cancer, solidifying his legacy as an influential figure in the medical community.

Publication Top Note

  1. The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
    Authors: Wenqi Wu, Yanan Jiang, Donghui Xing, Guibing Ren, Zhigang Zhao
    Year: 2024
    Citations: 3

Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Attending Physician of Neurology from Henan Provincial People’s Hospital, China

Dr. Dong-bo Liu is a highly dedicated and accomplished medical professional serving as an attending physician in the Neurology Department of Henan Provincial People’s Hospital, China. With a Doctor of Medicine degree, Dr. Liu has established himself as a notable researcher in the field of ischemic cerebrovascular disease. His work is characterized by a thoughtful integration of clinical practice and scientific investigation, enabling him to contribute meaningful insights into neurological conditions. Dr. Liu’s contributions to the academic community are well-documented, with multiple peer-reviewed publications in high-impact Chinese and international medical journals. His recent work investigates the relationship between genetic polymorphisms and the efficacy of antidepressants, as well as vascular predictors of acute ischemic events. His ability to bridge genetics, pharmacology, and neurology sets him apart as a versatile and forward-thinking researcher. In addition to his clinical responsibilities, Dr. Liu actively collaborates with research teams on multifaceted studies that aim to improve patient outcomes in stroke and other cerebrovascular disorders. Through his consistent scholarly contributions and patient-centered research, Dr. Liu has become a respected figure in neurology. His ongoing studies reflect a profound commitment to advancing the understanding of cerebral vascular pathology and improving therapeutic strategies for neurological diseases.

Professional Profile

Education

Dr. Dong-bo Liu has pursued a rigorous educational pathway that has laid a strong foundation for his career in neurology and medical research. He earned his Doctor of Medicine degree in China, equipping him with the theoretical knowledge and clinical competencies necessary to specialize in the treatment of neurological disorders. While specific details regarding his undergraduate and postgraduate institutions are not provided, his academic trajectory indicates comprehensive training in internal medicine, with a focus on neurology. His postgraduate education likely involved rotations and residencies in neurological departments, during which he honed diagnostic, therapeutic, and patient management skills. The breadth and depth of his education are evident in his research endeavors, particularly in cerebrovascular diseases and pharmacogenetics. Furthermore, Dr. Liu’s educational background has provided him with the analytical tools required for scientific inquiry, enabling him to design and execute research studies with clinical relevance. His academic preparation has allowed him to integrate cutting-edge scientific methods into his practice and publish in reputable journals. As a result, Dr. Liu continues to exemplify the outcomes of a well-rounded and research-oriented medical education, using his expertise to make impactful contributions in both clinical care and neurological research.

Professional Experience

Dr. Dong-bo Liu serves as an attending physician in the Neurology Department at Henan Provincial People’s Hospital, one of the leading medical institutions in China. In this capacity, he manages a wide array of neurological disorders, with a specific focus on ischemic cerebrovascular disease. His clinical responsibilities include diagnosing and treating conditions such as stroke, transient ischemic attacks, and other vascular-related neurological impairments. Dr. Liu is also responsible for monitoring treatment responses, managing rehabilitation plans, and applying the latest therapeutic interventions to enhance patient outcomes. In addition to his hands-on clinical role, Dr. Liu is deeply involved in research and academic activities. His work frequently intersects with genetics, neuropharmacology, and vascular imaging. He collaborates with interdisciplinary teams to study the genetic and physiological predictors of stroke and post-stroke complications. Dr. Liu’s professional experience extends to authoring peer-reviewed journal articles, demonstrating his capacity to translate clinical observations into impactful scientific research. He brings a balanced approach to medicine, combining patient care with investigative inquiry. Through his role at Henan Provincial People’s Hospital, Dr. Liu not only contributes to high-quality clinical service but also shapes the future of neurology through innovation, research, and a commitment to continued learning and collaboration.

Research Interests

Dr. Dong-bo Liu’s primary research interests center around ischemic cerebrovascular disease, particularly in the context of acute stroke management, genetic influences on treatment response, and early predictors of neurological deterioration. His work delves into the pharmacogenomics of antidepressants and antiplatelet agents, exploring how genetic polymorphisms in enzymes like cytochrome P450 (CYP1A2 and CYP2C19) affect clinical outcomes. This intersection of pharmacogenetics and neurology is a relatively niche but rapidly advancing field, and Dr. Liu’s studies offer valuable insights into personalized medicine. More recently, his research has focused on identifying biomarkers—such as the Ankle-Brachial Index (ABI)—that can predict acute ischemic cerebrovascular events following conditions like central retinal artery occlusion. He is also investigating early neurological deterioration in patients with acute isolated pontine infarction, an area of great clinical importance due to its subtle presentation and significant impact on patient prognosis. By identifying risk factors and potential early indicators, Dr. Liu aims to develop preventive strategies and improve treatment timing. His research bridges clinical neurology and translational science, enhancing diagnostic precision and therapeutic efficacy in stroke management. Ultimately, Dr. Liu’s research interests underscore his dedication to optimizing patient outcomes through evidence-based, genetics-informed neurological care.

Research Skills

Dr. Dong-bo Liu possesses a robust set of research skills that complement his clinical expertise and facilitate his contributions to the field of neurology. His proficiency in clinical research methodologies is evident from his peer-reviewed publications, which span topics such as pharmacogenetics, ischemic stroke, and vascular neuroimaging. Dr. Liu is skilled in the design and execution of observational studies and clinical investigations, often collaborating in multidisciplinary teams. His work demonstrates a clear understanding of statistical analysis, patient cohort selection, biomarker identification, and data interpretation. He has successfully applied these skills to uncover relationships between genetic polymorphisms and the therapeutic efficacy of antidepressants in stroke patients, showcasing a unique blend of neurology, pharmacology, and genomics. Dr. Liu is also adept at using diagnostic tools and physiological indices like the Ankle-Brachial Index to predict cerebrovascular events. Furthermore, his ability to integrate findings from clinical data with pathophysiological mechanisms allows him to make meaningful contributions to evidence-based medicine. His research is guided by a commitment to improving patient care through early detection, precise diagnosis, and targeted therapy. Overall, Dr. Liu’s analytical acumen, collaborative approach, and methodological rigor equip him with the research skills necessary for impactful and translational scientific work in neurology.

Awards and Honors

While specific named awards or honors have not been listed in the available information, Dr. Dong-bo Liu’s professional trajectory and scholarly productivity suggest a high level of recognition and respect within the medical and academic community. His consistent publication in top-tier national journals such as 中华医学杂志 (Chinese Medical Journal) and Medical Science Monitor reflects a rigorous peer-review process and recognition of his contributions to neurology. Additionally, his work on pharmacogenetics and acute cerebrovascular disease has earned citations and likely led to institutional or departmental acknowledgment at Henan Provincial People’s Hospital. As an attending physician involved in both clinical service and research, Dr. Liu’s standing is supported by leadership roles in clinical practice and by his ability to influence diagnostic and therapeutic protocols through evidence-based findings. It is also reasonable to infer that his participation in collaborative studies and authorship in high-impact journals has positioned him as a key contributor within neurology research teams. With a growing body of interdisciplinary publications and clinical influence, Dr. Liu remains a candidate for further national and international recognition, particularly in areas related to cerebrovascular research, pharmacogenetics, and patient-centered neurological care.

Conclusion

Dr. Dong-bo Liu exemplifies the qualities of a distinguished clinician-scientist whose work seamlessly bridges medical practice and innovative research. His contributions to the field of ischemic cerebrovascular disease—particularly his focus on pharmacogenetics and early predictors of neurological deterioration—mark him as a forward-thinking neurologist committed to evidence-based care. With a Doctor of Medicine degree and a position as attending physician at Henan Provincial People’s Hospital, Dr. Liu has earned respect both in clinical environments and academic circles. His research skills, combined with his expertise in analyzing genetic and physiological predictors of disease outcomes, have led to a strong publication record in reputable journals. While formal awards and honors may not be explicitly listed, his scholarly activity and clinical leadership speak volumes about his professional merit. Dr. Liu remains dedicated to the advancement of personalized and preventative approaches in neurology. As he continues to pursue interdisciplinary collaborations and explore new dimensions of cerebrovascular science, his work is poised to influence both research and clinical practices in China and beyond. Given his accomplishments and ongoing contributions, Dr. Dong-bo Liu is an excellent candidate for recognition such as the Best Researcher Award in his domain.

Publications Top Notes

  1. Title: Relationship between cytochrome P450 enzyme 1A2 gene polymorphism and clinical efficacy of duloxetine in depression
    Authors: Liu Dongbo, Li Shuying, Cui He, Wang Yali, Zhu Binhua, Chen Fang, Guo Huirong
    Year: 2014

  2. Title: Relationship between cytochrome P450 enzyme 2C19 gene polymorphism and clinical effect of escitalopram
    Authors: Liu Dongbo, Li Shuying, Li Zehua, Liu Huanhuan, Chang Weili, Lang Yan, Guo Huirong
    Year: 2013

  3. Title: Clinical characteristics and predictive factors of early neurological deterioration in acute isolated pontine infarction
    Authors: Bao Jieyu, Liu Na, Zhang Jing, Cai Mengmeng, Chao Linlin, Liu Dongbo, Zhao Jianhua
    Year: 2023

  4. Title: Relationship between central visual acuity and transient retinal ischemic attack in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  5. Title: The influence of ciliary retinal artery on central visual acuity in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  6. Title: Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Occlusion
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025

  7. Title: Association Between Ankle-Brachial Index and Risk of Early Neurological Deterioration After Acute Isolated Pontine Infarction
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025

Seyed Hassan Tonekaboni | Medicine and Dentistry | Outstanding Contribution Award

Posted on by ScienceFather

Dr. Seyed Hassan Tonekaboni | Medicine and Dentistry | Outstanding Contribution Award

Clinical Research Fellow from Shahid Beheshti Medical University, Iran

Dr. Seyed Hassan Tonekaboni is a distinguished Pediatric Neurologist and academic leader with over three decades of experience in clinical care, research, and medical education. He currently serves as a Clinical Research Fellow at the Autism Research Centre, Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada, under the supervision of Dr. Evdokia Anagnostou. Prior to this, he held the prestigious position of Full Professor in the Department of Pediatrics at Shahid Beheshti Medical University (SBMU) in Tehran, Iran, and was a senior staff pediatric neurologist at Mofid Children’s Hospital. His expertise lies in pediatric neurology, neurogenetics, epilepsy, and neurodevelopmental disorders. Dr. Tonekaboni has been instrumental in shaping child neurology services in Iran and has led numerous research initiatives addressing the diagnosis, treatment, and management of neurological conditions in children. His contributions extend to education, where he played key roles in postgraduate training and curriculum development. A respected voice in his field, he has served on national committees, editorial boards, and research centers, contributing significantly to pediatric neurology research in Iran and internationally. With a strong foundation in clinical practice and a growing international research portfolio, Dr. Tonekaboni is recognized for his enduring impact on child health and neurodevelopmental care.

Professional Profile

Education

Dr. Seyed Hassan Tonekaboni’s educational journey is both extensive and highly specialized, reflecting his deep commitment to pediatric neurology and medical genetics. He obtained his medical degree (MD) from Shahid Beheshti Medical University (SBMU), Tehran, in 1990. Following his general pediatric residency at the same institution, he pursued a subspecialty in Pediatric Neurology from 1996 to 1998, earning his national board certification in this field. To further enhance his expertise, Dr. Tonekaboni undertook a prestigious fellowship in Medical Genetics (AFSA: Attestation de Formation Spécialisée Approfondie) at Pierre and Marie Curie University and Pitié-Salpêtrière Hospital in Paris, France, from 2003 to 2004. His postgraduate training includes clinical research fellowships and observerships in Canada, including at the SickKids Hospital and the Autism Research Centre at Holland Bloorview in Toronto. These programs focused on neurogenetics, neuromuscular disorders, and autism spectrum conditions, broadening his clinical and research skills in international settings. His comprehensive educational background—spanning Iran, France, and Canada—has allowed him to integrate global best practices with regional expertise. This diverse academic foundation has greatly informed his approach to complex pediatric neurological disorders and has supported his leadership in clinical research and academic development in both national and international contexts.

Professional Experience

Dr. Seyed Hassan Tonekaboni has amassed a wealth of professional experience across clinical, academic, and research domains in pediatric neurology. His early career began at Mofid Children’s Hospital, where he served as a Staff Pediatrician and Clinician Educator from 1993 onward. Over the decades, he progressively held key academic roles at Shahid Beheshti Medical University (SBMU), becoming Assistant Professor in 2004, Associate Professor in 2005, and ultimately Full Professor by 2012. In these roles, he taught medical students and trained residents while managing pediatric neurology inpatient and outpatient services. From 2005 to 2017, he led the Medical Research Development Centre at Mofid Hospital, demonstrating his leadership in advancing research infrastructure. Dr. Tonekaboni has also held national positions, such as Vice Dean of Postgraduate Medical Education at SBMU, Vice President of the Iranian Neurogenetic Society, and a member of multiple Ministry of Health evaluation boards. His international engagement includes a research fellowship at Holland Bloorview Kids Rehabilitation Hospital in Canada, where he focuses on autism and neurodevelopmental research. His career reflects a deep commitment to integrating clinical excellence with research and policy development, making him a central figure in pediatric neurology in Iran and an emerging contributor in global pediatric neuroscience.

Research Interests

Dr. Seyed Hassan Tonekaboni’s research interests are grounded in pediatric neurology, with a particular emphasis on epilepsy, neurogenetic disorders, neurodevelopmental disabilities, and clinical pharmacology. His scholarly work spans several key domains, including the treatment and management of refractory epilepsy in children, neurocognitive outcomes of pharmacologic interventions, and the impact of dietary therapies like the ketogenic and Atkins diets on seizure control. Recently, his interests have expanded into neurodevelopmental disorders, including autism spectrum disorder (ASD), especially in the context of his ongoing clinical research fellowship in Canada. Dr. Tonekaboni is deeply invested in translational research that bridges clinical observations with practical therapeutic strategies. His studies often explore the efficacy and safety of antiepileptic drugs, diagnostic tools for genetic neurological conditions, and family-centered care approaches. He also investigates sociocultural factors influencing care delivery, such as maternal knowledge and attitudes toward childhood epilepsy. Through his involvement with national research centers and international academic institutions, Dr. Tonekaboni aims to contribute to evidence-based pediatric neurology practices. His multidisciplinary approach is informed by clinical observation, genetic science, and public health principles, making his work both scientifically valuable and socially relevant in improving outcomes for children with neurological disorders.

Research Skills

Dr. Tonekaboni possesses a comprehensive set of research skills that support his multidisciplinary approach to pediatric neurology. His clinical expertise enables him to design and conduct robust observational and interventional studies, particularly in epilepsy and neurodevelopmental disorders. He is well-versed in clinical trial design, including randomized controlled trials, as demonstrated in his investigations on the use of levetiracetam, buccal midazolam, and ketogenic diets for seizure control. His training in medical genetics has equipped him with skills in genetic diagnostics and the interpretation of genomic data, especially within the context of pediatric neurogenetic syndromes. Additionally, his experience at the Autism Research Centre and SickKids Hospital in Canada has expanded his competence in neurodevelopmental assessments and autism-related behavioral research. Dr. Tonekaboni is proficient in grant writing and has successfully secured research funding for multiple clinical studies. He also demonstrates strong academic writing and publication skills, contributing to peer-reviewed journals and serving on editorial boards. His leadership in research development at Mofid Children’s Hospital involved mentoring junior researchers and enhancing institutional research capacity. His methodological skills, combined with a collaborative mindset and clinical insight, make him adept at translating research findings into improved patient care strategies in pediatric neurology.

Awards and Honors

Over the course of his career, Dr. Seyed Hassan Tonekaboni has received numerous recognitions for his academic, clinical, and research achievements. Although specific named awards are not extensively listed, his honors are reflected in the prestigious positions he has held and the trust placed in him by national and institutional bodies. He has been appointed to critical national committees in Iran, including the Iranian National Board of Pediatric Neurology, the National Council of Neurology, and the Medical Graduate Evaluation Committee under the Ministry of Health. His election as Vice Dean of Postgraduate Medical Education and Head of the Research Development Centre at SBMU indicates high institutional recognition. Moreover, his selection as a fellow at internationally respected institutions—such as the Autism Research Centre in Canada and Pitié-Salpêtrière Hospital in France—reflects global recognition of his expertise and potential. He has also served as Chief Editor and Editorial Board Member for various scientific journals, such as the Iranian Journal of Child Neurology, confirming his scholarly influence. These appointments and invitations to contribute to academia, clinical service, and research infrastructure development are strong indicators of his outstanding contributions to pediatric neurology both nationally and internationally.

Conclusion

Dr. Seyed Hassan Tonekaboni is an accomplished pediatric neurologist and academic whose impact spans decades of clinical innovation, research leadership, and educational mentorship. His career reflects a seamless integration of clinical excellence and scholarly productivity, particularly in pediatric epilepsy, neurogenetics, and neurodevelopmental disorders. With a robust academic foundation and international collaborations in France and Canada, he has developed a global perspective on pediatric neurological care. Dr. Tonekaboni’s leadership roles in medical education, research administration, and national healthcare policy underscore his broad influence and commitment to advancing child health services in Iran and beyond. While his research visibility could be further amplified through increased high-impact international publications and global grant acquisition, his current portfolio demonstrates a substantial and meaningful contribution to medical science. His multidisciplinary approach, spanning clinical trials, genetics, education, and autism research, reflects his adaptability and dedication to addressing evolving challenges in pediatric neurology. In conclusion, Dr. Tonekaboni exemplifies the qualities of a seasoned clinician-scientist whose work continues to shape both academic scholarship and patient care. He is a strong candidate for recognition through awards that honor outstanding contributions to medical research and child neurological health.

Publications Top Notes

  • Title: Genetics of intellectual disability in consanguineous families
    Authors: H. Hu, K. Kahrizi, L. Musante, Z. Fattahi, R. Herwig, M. Hosseini, C. Oppitz, …
    Journal: Molecular Psychiatry, 24(7), 1027–1039
    Year: 2019
    Citations: 224

  • Title: Effect of inbreeding on intellectual disability revisited by trio sequencing
    Authors: K. Kahrizi, H. Hu, M. Hosseini, V.M. Kalscheuer, Z. Fattahi, M. Beheshtian, …
    Journal: Clinical Genetics, 95(1), 151–159
    Year: 2019
    Citations: 78

  • Title: Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity
    Journal: Neurogenetics, 7(3), 149–156
    Year: 2006
    Citations: 64

  • Title: GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): diagnosis and neuroimaging findings (an Iranian pediatric case series)
    Authors: P. Karimzadeh, N. Jafari, H.N. Biglari, S.J. Dari, F.A. Abadi, M.R. Alaee, …
    Journal: Iranian Journal of Child Neurology, 8(3), 55
    Year: 2014
    Citations: 61

  • Title: Efficacy of the Atkins diet as therapy for intractable epilepsy in children
    Authors: S.H. Tonekaboni, P. Mostaghimi, P. Mirmiran, A. Abbaskhanian, F.A. Gorji, …
    Journal: Archives of Iranian Medicine, 13(6), 492–497
    Year: 2010
    Citations: 60

  • Title: Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies
    Authors: Y. Nilipour, S. Nafissi, A.E. Tjust, G. Ravenscroft, H. Hossein Nejad Nedai, …
    Journal: European Journal of Neurology, 25(6), 841–847
    Year: 2018
    Citations: 50

  • Title: Neurocognitive effects of phenobarbital discontinuation in epileptic children
    Authors: S.H. Tonekaboni, N. Beyraghi, H.S. Tahbaz, S.A. Bahreynian, …
    Journal: Epilepsy & Behavior, 8(1), 145–148
    Year: 2006
    Citations: 48

  • Title: Knowledge, attitudes, and practices among mothers of children with epilepsy: a study in a teaching hospital
    Authors: A.A. Kolahi, M. Abbasi-Kangevari, P. Bakhshaei, F. Mahvelati-Shamsabadi, …
    Journal: Epilepsy & Behavior, 69, 147–152
    Year: 2017
    Citations: 47

  • Title: Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group
    Authors: MENA Pompe Working Group, F. Al Jasmi, M. Al Jumah, F. Alqarni, …
    Journal: BMC Neurology, 15, 1–17
    Year: 2015
    Citations: 47

  • Title: Bone mineral density in ambulatory children with epilepsy
    Authors: O. Yaghini, S.H. Tonekaboni, S.M. Amir Shahkarami, F. Ahmad Abadi, …
    Journal: The Indian Journal of Pediatrics, 82, 225–229
    Year: 2015
    Citations: 40

Sami Bahçebaşı | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Sami Bahçebaşı | Medicine and Dentistry | Best Researcher Award

Internal Medicine at Kayseri City Hospital, Turkey

Sami Bahçebaşı is an experienced internal medicine specialist with a strong background in clinical practice and research. Graduating from Hacettepe University Faculty of Medicine in 2006, he pursued specialization in Internal Medicine at Erciyes University in 2011. Over the years, he has worked in various hospitals, gaining extensive experience in patient care, diagnosis, and treatment. His dedication to medicine extends beyond clinical practice, as he actively contributes to research and healthcare improvements. Currently, he serves as an Internal Medicine Specialist at Kayseri City Hospital, where he manages complex cases and supports clinical education. His skills include patient management, evidence-based medicine, and clinical research. Though his primary language is Turkish, he has an intermediate command of English, which aids in his professional communication. His career objective is to become a distinguished academician and contribute significantly to medical research. While he has made valuable contributions to the field, further enhancement in research publications and international collaborations could elevate his recognition in the academic and medical communities. Sami Bahçebaşı’s continuous dedication to medicine and research makes him a promising figure in the field of internal medicine, with potential for further academic and professional achievements.

Professional Profile

Education

Sami Bahçebaşı completed his Bachelor of Medicine at Hacettepe University Faculty of Medicine in 2006, one of Turkey’s most prestigious medical institutions. His medical education provided him with a strong foundation in fundamental medical sciences, clinical knowledge, and patient care. Following his graduation, he pursued specialization in Internal Medicine at Erciyes University Faculty of Medicine, which he successfully completed in 2011. This specialization enhanced his expertise in diagnosing and managing complex internal medical conditions, preparing him for advanced clinical roles. His education included intensive training in various subfields of internal medicine, including cardiology, gastroenterology, nephrology, and endocrinology. Throughout his academic journey, he actively engaged in clinical rotations, patient case studies, and evidence-based medicine. His studies not only strengthened his medical knowledge but also instilled a research-oriented mindset, motivating him to contribute to scientific advancements. While he possesses a solid educational background, engaging in postgraduate research programs, Ph.D. studies, or fellowships could further enhance his academic standing and research credentials. His continuous pursuit of medical excellence reflects his commitment to lifelong learning and professional growth in the field of internal medicine.

Professional Experience

Sami Bahçebaşı has accumulated significant professional experience in the medical field, spanning nearly two decades. His career began in 2006 at Erciyes University, where he worked as a Medical Intern, gaining hands-on experience in clinical rotations across various departments. From 2011 to 2016, he served as a General Practitioner at District State Hospitals, providing primary healthcare services, diagnosing illnesses, and managing patient treatments in a rural hospital setting. His role involved handling a wide range of medical cases, enhancing his adaptability and problem-solving skills. In 2016, he joined Kayseri Training and Research Hospital as an Internal Medicine Specialist, where he focused on specialized patient care, clinical research, and medical education. Since 2018, he has been working at Kayseri City Hospital as an Internal Medicine Specialist, managing complex cases, collaborating with medical teams, and mentoring junior doctors. His extensive experience across different healthcare settings demonstrates his dedication to improving patient outcomes. While his expertise in internal medicine is well-established, assuming leadership roles in medical research or administrative positions could further solidify his influence in the medical and academic communities.

Research Interest

Sami Bahçebaşı’s research interests primarily revolve around internal medicine, with a focus on improving patient outcomes through clinical advancements and evidence-based medicine. His experience in hospital settings has exposed him to various chronic diseases, prompting his interest in research areas such as cardiovascular diseases, metabolic disorders, endocrinology, and nephrology. His involvement in research at Kayseri Training and Research Hospital suggests a keen interest in exploring innovative treatment approaches, disease prevention strategies, and public health improvements. Additionally, his clinical expertise in patient management and disease diagnosis positions him well for research in epidemiology, clinical trials, and medical education methodologies. To further develop his research profile, engaging in multicenter studies, publishing in high-impact journals, and participating in international medical conferences would be beneficial. Strengthening collaborations with academic institutions and research organizations could also enhance his contributions to the scientific community. While his current research involvement is commendable, expanding his work to include peer-reviewed publications and leadership roles in research projects would further establish him as a leading researcher in internal medicine.

Research Skills

Sami Bahçebaşı possesses several essential research skills that contribute to his effectiveness as a medical professional. His strong analytical skills enable him to critically evaluate medical cases, identify patterns, and interpret clinical data accurately. His experience in evidence-based medicine ensures that his research and clinical decisions are informed by the latest medical advancements and best practices. He is proficient in Microsoft Office Suite, which aids in data management, report writing, and presentation of research findings. Additionally, his moderate proficiency in English allows him to access and analyze international medical literature, although further improvement in language skills would enhance his ability to collaborate globally. His expertise in patient case studies, clinical audits, and medical reviews further demonstrates his research capabilities. To strengthen his research profile, acquiring advanced knowledge in statistical analysis tools (such as SPSS, R, or Python for medical research) and gaining experience in scientific writing for peer-reviewed publications would be highly beneficial. By enhancing his quantitative research methodologies and securing research funding or grants, he could further elevate his contributions to medical research and establish himself as a leading researcher in internal medicine.

Awards and Honors

While Sami Bahçebaşı has made significant contributions to internal medicine, no specific awards or honors are mentioned in his profile. However, his work at Kayseri Training and Research Hospital and Kayseri City Hospital reflects his commitment to medical excellence and research. His role in patient care, medical education, and clinical research indicates recognition within his professional community. To enhance his profile, actively pursuing awards related to clinical excellence, medical research, and healthcare innovation would be beneficial. He could aim for national or international medical awards, research grants, or fellowships to gain wider recognition for his contributions. Participating in medical conferences, research competitions, and academic collaborations could also increase his chances of being acknowledged for his work. Additionally, publishing high-quality research articles in reputable medical journals would improve his academic standing and eligibility for research awards. As he continues to grow in his field, his potential to receive honors and accolades will increase, further solidifying his reputation as a respected internal medicine specialist and researcher.

Conclusion

Sami Bahçebaşı is a dedicated internal medicine specialist with extensive experience in patient care and clinical research. His educational background from Hacettepe University and Erciyes University, coupled with his professional experience in various hospitals, highlights his strong expertise in internal medicine. His research interests in cardiovascular diseases, metabolic disorders, and evidence-based medicine position him as a promising contributor to medical advancements. While he has essential research skills, further enhancing his scientific writing, data analysis, and international collaborations would significantly boost his research profile. Although no awards or honors are currently listed, his commitment to clinical excellence and research suggests strong potential for future recognition. To elevate his career, publishing in high-impact journals, leading research projects, and pursuing academic fellowships would be beneficial. Overall, Sami Bahçebaşı demonstrates great promise as a medical professional and researcher. With continued efforts in research leadership and international collaboration, he could emerge as a distinguished academician and a leading figure in internal medicine research.

Publications Top Notes

  1. “Advantages of Peritoneal Dialysis Over Hemodialysis”

    • Author(s): Sami Bahçebaşı
    • Year: 2022

  2. “The role of oxidants and antioxidative parameters in patients with hepatic encephalopathy”

    • Author(s): Sami Bahçebaşı
    • Year: 2021

  3. “Fear of hypoglycemia in adults with diabetes mellitus switching to treatment with IDegAsp co-formulation to examine real-world setting: an observational study (The HATICE study)”

    • Author(s): Ulaş Serkan Topaloğlu, Hatice Kayış Topaloğlu, Melih Kızıltepe, Mesut Kılıç, Sami Bahçebaşı, Sibel Ata, Şeyma Yıldız, Yasin Şimşek
    • Year: 2020

  4. “Unusual clinical presentation of ethylene glycol poisoning: unilateral facial nerve paralysis”

    • Author(s): Sami Bahçebaşı
    • Year: 2013

  5. “Improvement in culture-negative peritoneal dialysis-related peritonitis: a single center’s experience”

    • Author(s): Sami Bahçebaşı
    • Year: 2012

  6. “Efficacy and safety of deferasirox in patients undergoing stem cell transplantation in post-transplant period”

    • Author(s): Sivgin, S.; Bahcebasi, S.; Kaynar, L.; Kurnaz, F.; Koker, Y.; Cetin, M.; Unal, A.; Eser, B.
    • Year: 2011

  7. “Hepatic and Renal Dysfunction After Using Lavandula Stoechas and Melissa Officinalis Herbal”

    • Author(s): Bahcebasi, Sami; Kocyigit, Ismail; Ucar, Cahit; Unal, Aydin; Oymak, Oktay; Utas, Cengiz
    • Year: 2011

  8. “Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)”

    • Author(s): Unknown (needs further verification)
    • Year: 2011

Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

MD PhD (resident in pediatrics) at Sheba Medical Center, Israel.

Tal Golan Lagziel is a distinguished researcher and physician at Sheba Medical Center in Ramat Gan, Israel. He holds an M.D. and Ph.D. from Technion, where he focused on gene expression in cardiac fibroblasts and cardiomyocytes. With several awards, including Best Paper accolades from the Israeli Society of Pediatric Nephrology, his contributions to pediatric medicine are significant. Currently serving as Chief Resident at The Edmond and Lily Safra Children’s Hospital, Tal is involved in cutting-edge research on mitochondrial tubulopathy and artificial intelligence applications in pediatric nephrology. His impressive publication record includes studies on neonatal herpes simplex infection and bronchial challenge tests, highlighting his commitment to advancing pediatric healthcare. Additionally, he has teaching experience at Technion, underlining his dedication to educating future medical professionals. Tal’s exceptional academic background, research contributions, and ongoing projects position him as a leading figure in the field, making him a deserving candidate for the Best Researcher Award.

Profile:

Education

Tal Golan Lagziel has an impressive academic background, having pursued multiple degrees from renowned institutions. He completed his Ph.D. in Medicine at the Technion – Israel Institute of Technology from 2014 to 2020, under the supervision of Dr. Itzhak Kehat. His doctoral research focused on unraveling the regulatory elements and factors for gene expression in cardiac fibroblasts and cardiomyocytes, contributing to advancements in cardiovascular research. Alongside his Ph.D., he earned his M.D. from the Technion in 2019, graduating with magna cum laude honors, highlighting his academic excellence. Prior to this, he completed a B.Sc. in Medical Sciences and a B.Sc. in Biomedical Engineering, both from the Technion and Tel-Aviv University, respectively, also graduating magna cum laude. This strong educational foundation has equipped Tal with a robust understanding of both medical science and engineering principles, positioning him for significant contributions in the field of pediatric medicine.

Professional Experience

Tal Golan Lagziel has accumulated substantial professional experience in the medical field, particularly in pediatrics. Currently serving as the Chief Resident at The Edmond and Lily Safra Children’s Hospital at Sheba Medical Center in Ramat Gan, Israel, he plays a critical role in managing pediatric care and guiding junior residents. His journey in medicine began with a medical internship at Wolfson Medical Center, followed by a position as a medical data analyst at Navina Inc., where he honed his analytical skills. Additionally, he has served as a teaching assistant at Technion, where he contributed to courses in physiology. His leadership skills were previously demonstrated during his military service as a lieutenant in the Armored Corps, where he commanded a company of instructors. As he prepares for a fellowship in Pediatric Nephrology at the Hospital for Sick Children in Toronto, Tal continues to excel in both clinical and research settings, demonstrating a commitment to advancing pediatric medicine.

Research Interest

Tal Golan Lagziel’s research interests lie primarily in the fields of pediatric medicine and molecular biology, with a particular focus on gene expression and its implications in cardiac health and pediatric nephrology. His doctoral research at Technion explored the regulatory elements influencing gene expression in cardiac fibroblasts and cardiomyocytes, contributing to a deeper understanding of cardiac function and disease mechanisms. Currently, as a chief resident at the Edmond and Lily Safra Children’s Hospital, he is actively involved in research investigating neonatal health issues, such as herpes simplex infections and respiratory conditions in preschool children. Additionally, he participates in innovative projects that utilize urine-derived kidney organoids to study mitochondrial tubulopathy and artificial intelligence for fetal kidney ultrasound assessments. Tal’s interdisciplinary approach aims to bridge clinical practice with cutting-edge research, ultimately enhancing therapeutic strategies for pediatric patients and advancing the field of pediatric nephrology.

Research Skills

Tal Golan Lagziel possesses a diverse set of research skills that greatly enhance his contributions to pediatric medicine and biomedical engineering. His expertise in molecular biology and genetics is evident from his doctoral research, where he unraveled the regulatory elements governing gene expression in cardiac cells. Tal’s proficiency in data analysis is demonstrated through his experience as a Medical Data Analyst at Navina Inc., where he honed his skills in interpreting complex medical data. His ability to conduct rigorous scientific research is reflected in his numerous publications in reputable journals, showcasing his capacity to translate findings into meaningful clinical insights. Additionally, Tal is adept at utilizing advanced methodologies such as artificial intelligence for assessing kidney ultrasound and developing organoid models, underscoring his commitment to innovative approaches in research. Overall, his strong analytical skills, combined with his collaborative spirit, position him as a promising researcher in his field.

Award and Recognition

Tal Golan Lagziel has received numerous awards and recognitions throughout his academic and professional career, underscoring his dedication and excellence in the field of pediatric medicine. Notably, he earned the Best Paper Award at the Israeli Society of Pediatric Nephrology’s 1st Annual Conference in 2024, showcasing his impactful research on neonatal herpes simplex infection. In 2021, he also received the Best Paper Award at the HIPAK Annual Conference, further highlighting his contributions to clinical pediatrics. Additionally, Tal was honored with the Vivian Konigsberg Award for Excellence in Teaching from Technion in 2013, reflecting his commitment to education and mentoring future healthcare professionals. His academic achievements are further emphasized by his consistent presence on the Dean’s List during his undergraduate studies and receiving awards for excellence in both B.Sc. studies at Technion and Tel-Aviv University. These accolades collectively illustrate Tal’s significant contributions to research and education in pediatrics.

Conclusion

Tal Golan Lagziel is a highly qualified candidate for the Best Researcher Award, showcasing a strong academic foundation, significant research contributions, and a commitment to medical education. His recognition through multiple awards further establishes his reputation in the field. Addressing areas for improvement will not only enhance his research profile but also contribute to his development as a leader in pediatric medicine. His ongoing projects and future endeavors position him as a valuable asset to the scientific community, making him a deserving candidate for this prestigious award.

Publication Top Notes

  • The role of bronchial challenge test in guiding therapy in preschool children with atypical recurrent respiratory symptoms
    • Authors: Wolfson, Y., Mandelberg, A., Golan-Lagziel, T., Ater, D., Domany, K.A.
    • Year: 2024
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 59(2), pp. 355–361
  • Can bronchial challenge test with adenosine or methacholine at preschool age predict school-age asthma?
    • Authors: Golan-Lagziel, T., Mandelberg, A., Wolfson, Y., Ater, D., Armoni Domany, K.
    • Year: 2021
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 56(10), pp. 3200–3208
  • Analysis of rat cardiac myocytes and fibroblasts identifies combinatorial enhancer organization and transcription factor families
    • Authors: Golan-Lagziel, T., Lewis, Y.E., Shkedi, O., Caspi, L.H., Kehat, I.
    • Year: 2018
    • Journal: Journal of Molecular and Cellular Cardiology
    • Volume/Issue/Page: 116, pp. 91–105

 

 

 

Hyun-Soo Choi | Medical Domain | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Hyun-Soo Choi | Medical Domain | Best Researcher Award

Assistant Professor at Seoul National University of Science and Technology, South Korea

Dr. Hyun-Soo Choi is an Assistant Professor in the Department of Computer Science and Engineering at Seoul National University of Science and Technology. He holds a Ph.D. in Electrical and Computer Engineering from Seoul National University. His research focuses on artificial intelligence, machine learning, deep learning, biomedical data learning, and causal inference. With significant contributions to the field, Dr. Choi has published extensively in renowned journals, including IEEE Transactions on Neural Networks and Learning Systems and the Journal of Clinical Medicine. His work on deep learning-based medical diagnostics and imbalanced data classification has garnered attention for its innovative approaches and practical applications. In addition to his academic role, he serves as the Chief Technical Officer at Ziovision and has previously worked as a researcher at SK Telecom. Dr. Choi has received accolades such as the Annual Excellence Award from Seoul National University, recognizing his impactful research and academic achievements.

Profile

Education

Dr. Hyun-Soo Choi’s educational journey is marked by distinguished achievements and a solid foundation in engineering and computer science. He earned his Bachelor of Science degree in Computer and Communication Engineering from Korea University in February 2013, where he developed a strong base in computing principles. He then pursued advanced studies at Seoul National University, completing his Ph.D. in Electrical and Computer Engineering in February 2020. During his doctoral studies, he was supervised by Prof. Sungroh Yoon and focused on “Imbalanced Data Learning: Advances in Techniques and Applications,” contributing significant advancements to the field of artificial intelligence and machine learning. This academic background not only reflects his expertise in data analysis and bio-medical data learning but also highlights his commitment to advancing knowledge through innovative research.

Professional Experience

Dr. Hyun-Soo Choi has accumulated a diverse range of professional experiences across academia and industry. Currently, he serves as an Assistant Professor in the Department of Computer Science and Engineering at Seoul National University of Science and Technology since February 2023. In this role, he teaches advanced courses in programming, natural language processing, and deep learning. Concurrently, Dr. Choi is the Chief Technical Officer at Ziovision, overseeing technological innovations and developments since October 2021. Previously, he was an Assistant Professor at Kangwon National University from March 2021 to February 2023, where he contributed to various courses on data analysis and machine learning. Dr. Choi also has experience as a researcher at SK Telecom’s T-brain, focusing on advanced artificial intelligence applications from February 2020 to February 2021. His academic background includes a Ph.D. from Seoul National University, where he was mentored by Prof. Sungroh Yoon.

 Research Interest

Dr. Hyun-Soo Choi’s research focuses on advanced artificial intelligence (AI) and machine learning techniques, with a particular emphasis on deep learning, universal learning machines, and causal inference. His work addresses the challenges of bio-medical data learning, aiming to enhance the accuracy and efficiency of data-driven healthcare solutions. Dr. Choi’s research contributions include developing innovative algorithms for imbalanced data learning and applying deep learning methods to various medical fields, such as organ localization and ECG analysis. His recent projects explore novel approaches in facial fracture detection, drug monitoring, and real-time health monitoring, underscoring his commitment to translating AI advancements into practical medical applications. By integrating interdisciplinary methodologies, Dr. Choi strives to push the boundaries of AI research, improving diagnostic and predictive capabilities in healthcare and beyond.

 Research Skills

Dr. Hyun-Soo Choi exhibits a broad and advanced skill set in artificial intelligence and machine learning, particularly in deep learning, causal inference, and bio-medical data analysis. His expertise spans a range of research techniques, including the development of advanced algorithms for imbalanced data learning and generative adversarial networks (GANs). Dr. Choi is proficient in employing deep learning models for diverse applications, such as facial fracture detection, organ localization in wireless capsule endoscopy, and electrocardiography analysis. His ability to integrate machine learning methods with real-world medical data demonstrates a strong aptitude for translating complex theoretical models into practical solutions. Additionally, Dr. Choi’s experience with causal inference methods and universal learning machines highlights his skill in handling intricate data structures and extracting meaningful insights. His comprehensive understanding of these areas is evident through his numerous high-impact publications and contributions to cutting-edge research in his field.

Conclusion

Dr. Hyun-Soo Choi is a strong candidate for the “Research for Best Researcher Award” due to his prolific research output, interdisciplinary expertise, and leadership roles in both academia and industry. However, to further strengthen his application, it would be beneficial to highlight his success in securing research funding, previous awards or recognitions, mentorship activities, and the broader societal impact of his research. With these additions, Dr. Choi would present a well-rounded profile that exemplifies excellence in research and its application to solving real-world challenges.

 

Publications Top Notes

  • A Comprehensive Study on a Deep-Learning-Based Electrocardiography Analysis for Estimating the Apnea-Hypopnea Index
    • Authors: Kim, S., Choi, H.-S., Kim, D., … Kim, Y., Lee, W.H.
    • Year: 2024
  • A Deep Learning–Based Approach for Prediction of Vancomycin Treatment Monitoring: Retrospective Study Among Patients With Critical Illness
    • Authors: Kim, D., Choi, H.-S., Lee, D., … Park, J.-H., Park, J.
    • Year: 2024
    • Citations: 1
  • Early Prediction of Mortality for Septic Patients Visiting Emergency Room Based on Explainable Machine Learning: A Real-World Multicenter Study
    • Authors: Park, S.W., Yeo, N.Y., Kang, S., … Lim, C.-M., Heo, J.
    • Year: 2024
    • Citations: 2
  • Explicit Feature Interaction-Aware Graph Neural Network
    • Authors: Kim, M., Choi, H.-S., Kim, J.
    • Year: 2024
    • Citations: 1
  • In-Advance Prediction of Pressure Ulcers via Deep-Learning-Based Robust Missing Value Imputation on Real-Time Intensive Care Variables
    • Authors: Kim, M., Kim, T.-H., Kim, D., … Han, S.-S., Choi, H.-S.
    • Year: 2024
  • Improving Generalization Performance of Electrocardiogram Classification Models
    • Authors: Han, H., Park, S., Min, S., … Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 3
  • On the Impact of Knowledge Distillation for Model Interpretability
    • Authors: Han, H., Siwon, K., Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 1
  • Multi-View Computed Tomography Network for Osteoporosis Classification
    • Authors: Hwang, D.H., Bak, S.H., Ha, T.-J., … Kim, W.J., Choi, H.-S.
    • Year: 2023
    • Citations: 1
  • PixelSteganalysis: Pixel-Wise Hidden Information Removal With Low Visual Degradation
    • Authors: Jung, D., Bae, H., Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 3
  • ConBERT: A Concatenation of Bidirectional Transformers for Standardization of Operative Reports from Electronic Medical Records
    • Authors: Park, S., Bong, J.-W., Park, I., … Choi, H.-S., Kang, S.
    • Year: 2022
    • Citations: 1